![Foto de Fernando](/img/nophoto.png)
Fernando
Vidal Vanaclocha
Publicaciones en las que colabora con Fernando Vidal Vanaclocha (9)
2012
-
Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis
Gut, Vol. 61, Núm. 10, pp. 1465-1472
2011
-
Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18
Journal of Translational Medicine, Vol. 9
2003
-
Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis
Hepatology, Vol. 37, Núm. 3, pp. 674-685
-
Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
Methods in molecular medicine, Vol. 85, pp. 79-86
2002
-
Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium
Hepatology, Vol. 35, Núm. 5, pp. 1104-1116
1998
-
Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver
Journal of Cellular Physiology, Vol. 174, Núm. 3, pp. 322-330
1997
-
Characterization of a new human liver myofibroblast cell line: Transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor β1
Laboratory Investigation, Vol. 77, Núm. 1, pp. 63-70
-
Interleukin 1-dependent and -independent mouse melanoma metastases
Journal of the National Cancer Institute, Vol. 89, Núm. 9, pp. 645-651
-
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis
Hepatology, Vol. 26, Núm. 3, pp. 634-642